From January 1, 2023 to March 31, 2023, the company has repurchased 29,705,344 shares, representing 1.54% for CNY 369.96 million. With this, the company has completed the repurchase of 40,662,579 shares, representing 2.13% for CNY 494.49 million under the buyback announced on December 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.49 CNY | -0.16% | -2.19% | +0.48% |
05-28 | China Approves Joincare Unit's Asthma Drug | MT |
04-25 | Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.48% | 3.22B | |
+39.83% | 731B | |
+31.34% | 586B | |
-7.41% | 348B | |
+16.59% | 319B | |
+0.40% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+7.49% | 202B | |
+3.76% | 159B |
- Stock Market
- Equities
- 600380 Stock
- News Joincare Pharmaceutical Group Industry Co.,Ltd.
- Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.